Friday, January 28, 2022
HomeHEALTHMerck’s antiviral COVID-19 capsule permitted by U.S. FDA for at-home use -...

Merck’s antiviral COVID-19 capsule permitted by U.S. FDA for at-home use – National | Globalnews.ca


The U.S. Food and Drug Administration on Thursday approved Merck & Co’s antiviral capsule for COVID-19, after giving the go-ahead to the same remedy from Pfizer Inc. a day earlier.

Merck’s drug, molnupiravir, developed with Ridgeback Biotherapeutics, was proven to cut back hospitalizations and deaths by round 30 per cent in a medical trial of high-risk people early in the middle of the sickness.

The company approved the oral drug for the remedy of mild-to-moderate COVID-19 in adults who’re in danger for extreme illness, and for whom different COVID-19 therapies will not be accessible or clinically acceptable.

The U.S. authorities has a contract to purchase as many as 5 million programs of the drug for $700 per course.

Story continues under commercial

The drug will not be approved to be used in sufferers youthful than 18 as a result of molnupiravir could have an effect on bone and cartilage progress, the FDA stated in an announcement.


Click to play video: 'Merck Canada announces its antiviral COVID-19 treatment will be manufactured in Ontario'







Merck Canada declares its antiviral COVID-19 remedy might be manufactured in Ontario


Merck Canada declares its antiviral COVID-19 remedy might be manufactured in Ontario – Dec 6, 2021






RELATED ARTICLES
- Advertisment -

Most Popular

Recent Comments